載入...
MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments
The MEK5-ERK5 pathway is a mammalian mitogen-activated protein (MAP) kinase cascade that is not well studied compared to other MAP kinase cascades. Two independent studies by Al-Ejeh et al. and Ortiz-Ruiz et al. published in Oncotarget last year concluded that ERK5 is an attractive target in triple...
Na minha lista:
| 發表在: | Oncoscience |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381702/ https://ncbi.nlm.nih.gov/pubmed/25859552 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|